Prevention of thromboembolism with use of recombinant hirudin. Results of a double-blind, multicenter trial comparing the efficacy of desirudin (revase) with Thai of unfractionated heparin in patients having a total hip replacement

Journal of Bone and Joint Surgery

Volumn 79, Issue 3, 1997, Pages 326-333

  Eriksson, Bengt I ^a,c,e   Ekman, Steffan ^b   Lindbratt, Siv ^a,c,f   Baur, Markus ^b   Bach, Doris ^b   Tørholm, Carsten ^d,g   Kälebo, Peter ^a,c,e   Close, Philippe ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b CIBA GEIGY LTD   (Switzerland)

^c NOVARTIS PHARMA AG   (Switzerland)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^f Box 1150   (Sweden)

^g UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DESULFATOHIRUDIN; HEPARIN; LEPIRUDIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEMATOMA; HUMAN; LUNG ANGIOGRAPHY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PARTIAL THROMBOPLASTIN TIME; PHLEBOGRAPHY; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOEMBOLISM; TOTAL HIP PROSTHESIS; WOUND DEHISCENCE;

EID: 0030953595     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/00004623-199703000-00002     Document Type: Article

References (29)

1. Bergqvist, D.: Incidence of pulmonary embolism. In Postoperative Thromboembolism. Frequency, Etiology, Prophylaxis, pp. 24-30. New York, Springer, 1983.
2. Bichler, J.; Fichtl, B.; Siebeck, M.; and Fritz, H.: Pharmacokinetics and pharmacodynamics of hirudin in man after single subcutaneous and intravenous bolus administration. Arzneimittel-Forschung, 38: 704-710, 1988.
3. Biello, D. R.; Mattar, A. G.; McKnight, R. C.; and Siegel, B. A.: Ventilation-perfusion studies in suspected pulmonary embolism. AJR: Am. J. Roentgenol., 133: 1033-1037, 1979.
4. Clagett, G. P.; Anderson, F. A., Jr.; Heit, J.; Levine, M. N.; and Wheeler, H. B.: Prevention of venous thromboembolism. Chest, 108 (4 Supplement): 312S-334S, 1995.
5. Collins, R.; Scrimgeour, A.; Yusuf, S.; and Peto, R.: Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologie surgery. New England J. Med., 318: 1162-1173, 1988.
6. Colwell, C. W., Jr.; Spiro, T. E.; Trowbridge, A. A.; Morris, B. A.; Kwaan, H. C.; Blaha, J. D.; Comerota, A. J.; and Skoutakis, V. A.: Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. J. Bone and Joint Surg., 76-A: 3-14, Jan. 1994.
7. Eriksson, B. I.; Kälebo, P.; Anthmyr, B. A.; Wadenvik, H.; Tengborn, L.; and Risberg, B.: Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparin. J. Bone and Joint Surg., 73-A: 484-493, April 1991.
8. Eriksson, B. I.; Kälebo, P.; Ekman, S.; Lindbratt, S.: Kerry, R.; and Close, P.: Direct thrombin inhibition with rec-hirudin CGP 39393 as prophylaxis of thromboembolic complications after total hip replacement. Thromb. and Haemost., 72:227-231, 1994.
9. Eriksson, B. I.; Kälebo, P.; Ekman, S.; Baur, M.; Bach, D.; Kerry, R.; and Close, P.: A dose-finding trial evaluating the efficacy and safety of three different doses of recombinant hirudin, CGP 39393 (Revasc-Ciba), in patients undergoing total hip replacement [abstract]. Thromb. and Haemost., 73: 1108, 1995.
10. Hauptmann, J.; Bruggener, E.; and Markwardt, F.: Effect of heparin, hirudin, and a synthetic thrombin inhibitor on antithrombin III in thrombin-induced disseminated intravascular coagulation in rats. Haemostasis, 17: 321-328, 1987.
11. Havig, Ö.: Deep vein thrombosis and pulmonary embolism. An autopsy study with multiple regression analysis of possible risk factors. Acta Chir. Scandinavica, Supplementum 478, 1977.
12. Hull, R. D.; Hirsh, J.; Carter, C. J.; Jay, R. M.; Dodd, P. E.; Ockelford, P. A.; Coates, G.; Gill, G. J.; Turpie, A. G.; Doyle, D. J.; Buller, H. R.; and Raskob, G. E.: Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann. Intern. Med., 98: 891-899, 1983.
13. Hull, R.; Raskob, G.; Pineo, G.; Rosenbloom, D.; Evans, W.; Mallory, T.; Anquist, K.; Smith, F.; Hughes, G.; Green, D.; Elliott, C. G.; Panju. A.; and Brant, R.: A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. New England J. Med., 329: 1370-1376, 1993.
14. Kaiser, B., and Markwardt, F.: Antithrombotic and haemorrhagic effects of synthetic and naturally occurring thrombin inhibitors. Thromb. Res., 43: 613-620, 1986.
15. Kälebo, P.; Anthmyr, B, A.; Eriksson, B. I.; and Zachrisson, B. E.: Phlebographic findings in venous thrombosis following total hip replacement. Acta Radiol., 31: 259-263, 1990.
16. Leizorovicz, A.; Haugh, M. C.; Chapuis, F. R.; Samama, M. M.; and Boissel, J. P.: Low molecular weight heparin in prevention of perioperative thrombosis. British Med. J., 305: 913-920, 1992.
17. Marbet, G. A.; Verstraete, M.; Kienast, J.; Graf, P.; Hoet, B.; Tsakiris, D. A.; Silling-Engelhardt, G.; and Close, P.: Clinical pharmacology of intravenously administered recombinant desulfatohirudin (CGP 39393) in healthy volunteers. J. Cardiovasc. Pharmacol., 22: 364-372, 1993.
18. Markwardt, F.; Hauptmann, J.; Nowak, G.; Klessen, C.; and Walsmann, P.: Pharmacological studies on the antithrombotic action of hirudin in experimental animals. Thromb. and Haemost., 47: 226-229, 1982.
19. Markwardt, F.; Nowak, G.; Stürzebecher, J.; Griessbach, U.; Walsmann, P.; and Vogel, G.: Pharmacokinetics and anticoagulant effect of hirudin in man. Thromb. and Haemost., 52: 160-163, 1984.
20. Moser, K. M., and LeMoine, J. R.: Is embolie risk conditioned by location of deep venous thrombosis? Ann. Intern. Med., 94: 439-444, 1981.
21. Nurmohamed, M. T.; Rosendaal, F. R.; Büller, H. R.; Dekker, E.; Hommes, D. W.; Vandenbroucke, J. P.; and Briët, E.: Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet, 340: 152-156, 1992.
22. Rabinov, K., and Paulin, S.: Roentgen diagnosis of venous thrombosis in the leg. Arch. Surg., 104: 134-144, 1972.
23. Rules Governing Medicinal Products in the European Community: Vol. III (Addendum), July 1990. Guidelines for good clinical practice and directive 91/507/EEC. European GCP guidelines. Good Clin. Pract. J., 1 (Supplement 1), 1994.
24. Rules Governing Medicinal Products in the European Community: Vol. III (Addendum), July 1990. Guidelines for good clinical practice and directive 91/507/EEC. European GCP guidelines. Good Clin. Pract. J., 1 (Supplement 1), 1994.
25. Skinner, J. A.; Gerrard, D. J.; Zahn, H.; Cohen, A. T.; Porteous, M. J. L.; and Thomas, E. M.: An assessment of deep venous function following total hip arthroplasty complicated by venographically proven deep vein thrombosis [abstract]. Thromb. and Haemost., 73: 1110, 1995.
26. Talbot, M. D.; Ambler, J.; and Butler, K. D.: Recombinant desulphatohirudin (CGP 39393): comparative studies with standard and low molecular weight heparin. Internat. Soc. Appl. Cardiovasc. Bio., 1: 131-146, 1990.
27. Verstraete, M.; Nurmohamed, M.; Kienast, J.; Siebeck, M.; Silling-Engelhardt, G.; Buller, H.; Hoet, B.; Bichler, J.; and Close, P.: Biologic effects of recombinant hirudin (CGP 39393) in human volunteers. European Hirudin in Thrombosis Group. J. Am. Coll. Cardiol., 22: 1080-1088, 1993.
28. Wildsmith, J. A., and McClure, J. H.: Anticoagulant drugs and central nerve blockade. Anaesthesia, 46: 613-614, 1991.
29. Zachrisson, B. E., and Jansen, H.: Phlebographic signs in fresh postoperative venous thrombosis of the lower extremity. Acta Radiol. Diag., 14: 82-96, 1973.